Catherine A. Sohn Insider Trading $SNCA PALISADE BIO, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Catherine A. Sohn.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Catherine A. Sohn. Catherine A. Sohn is in LANDEC CORP \CA\ ($LNDC) and Director in LANDEC CORP \CA\ ($LNDC) and Director in Jazz Pharmaceuticals plc ($JAZZ) and Director in Neuralstem, Inc. ($CUR) and Director in Axcella Health Inc. ($AXLA) and Director in Rubius Therapeutics, Inc. ($RUBY).

Catherine A. Sohn in PALISADE BIO, INC.

Trading Symbol: SNCA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Catherine A. Sohn: Director
Holdings: 106,952 shares
Current Value: $322,995
Latest Transaction: Jul 06 2015
$SNCA Market Capitalization: $28.01M
$SNCA Previous Close: $3.02

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Catherine A. Sohn in PALISADE BIO, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AXLA, JAZZ, LNDC, SNCA, RUBY

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 06 2015CURNeuralstem, Inc.Sohn Catherine A.DirectorGrantA0.00106,9520106,9520 to 107 K

Page:   1